The present investigation yielded MMP7, MMP10 and MMP12 serum levels in a homogenous group of colon cancer patients to be adverse prognostic molecular markers exerting valid multiplex bead-based immunoassay - technologies. This evidence concerns the gene MMP12 and malignant colon neoplasm.